Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Upcoming Workshop Is Last Stop Before Proposed Unique Identifier Rule

This article was originally published in The Gray Sheet

Executive Summary

A proposed rule to implement mandatory unique device identification is anticipated by CDRH staffers to be ready by year-end, with input from an upcoming public meeting

You may also be interested in...



Industry Groups Say Unique Device ID Requirements Should Be Risk-Based

When it comes time to implement a unique identifier system for devices, the riskiest products should be tackled first, manufacturers, suppliers and some FDA staffers agree

Industry Groups Say Unique Device ID Requirements Should Be Risk-Based

When it comes time to implement a unique identifier system for devices, the riskiest products should be tackled first, manufacturers, suppliers and some FDA staffers agree

Parting Words: Larry Kessler Urges CDRH To Put Science Over Clinical Hopes

For longtime FDA staffer Larry Kessler, now is a hard time to be leaving the agency

Related Content

Topics

UsernamePublicRestriction

Register

MT027046

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel